We are live on ! Find out more
IE

Israel Englander Millennium Management

AUM $276B
1-Year Est. Return 44.8%
 

Israel “Izzy” Englander is the founder of Millennium Management, one of the world’s largest multi-strategy hedge fund platforms. Millennium allocates capital across hundreds of independent teams rather than a single house view, with rigorous risk controls at the platform level. Englander’s model has been highly influential in the rise of pod-shop multi-manager structures across the industry.

This Fund
S&P 500
This Quarter Est. Return
-0.14%
1 Year Est. Return
+44.8%
3 Year Est. Return
+127.22%
5 Year Est. Return
+155.52%
10 Year Est. Return
+768.06%
AUM
$167B
AUM Growth
+$3.7B
Cap. Flow
-$692M
Cap. Flow %
-0.42%
Top 10 Hldgs %
18.31%
Holding
7,698
New
1,245
Increased
2,719
Reduced
2,446
Closed
981

Top Buys

Rank Stock Value
1
SPY icon
State Street SPDR S&P 500 ETF Trust
SPY
+$643M
2
T icon
AT&T
T
+$311M
3
XLK icon
State Street Technology Select Sector SPDR ETF
XLK
+$306M
4
MSFT icon
Microsoft
MSFT
+$292M
5
AME icon
Ametek
AME
+$215M

Top Sells

Rank Stock Value
1
ALXN
Alexion Pharmaceuticals
ALXN
+$887M
2
AAPL icon
Apple
AAPL
+$694M
3
PRAH
PRA Health Sciences, Inc.
PRAH
+$616M
4
AMZN icon
Amazon
AMZN
+$596M
5
LIN icon
Linde
LIN
+$531M

Sector Composition

Rank Sector Weight
1 Miscellaneous 58.05%
2 Technology 7.69%
3 Financials 6.83%
4 Healthcare 6.42%
5 Industrials 4.98%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake 		Capital Flow
GFX.U
4351
DELISTED
Golden Falcon Acquisition Corp. Units, each consisting of one share of Class A Common Stock and one-half of one Warrant
GFX.U
$1.3M ﹤0.01%
129,963
– –
MBCN
4352
DELISTED
Middlefield Banc Corp
MBCN
$1.3M ﹤0.01%
53,890
-41,742
-44% -$990K
SAVE
4353
CALL
DELISTED
Spirit Airlines, Inc.
SAVE
$1.3M ﹤0.01%
+50,000
New +$1.31M
BIOT
4354
DELISTED
Biotech Acquisition Company Class A Ordinary Shares
BIOT
$1.3M ﹤0.01%
133,151
+96,000
+258% +$930K
KRYS icon
4355
Krystal Biotech
KRYS
$10.4B
$1.29M ﹤0.01%
+24,810
New +$1.47M
CLYM
4356
Climb Bio
CLYM
$837M
$1.29M ﹤0.01%
+71,983
New +$1.49M
TMTS
4357
DELISTED
Spartacus Acquisition Corporation Class A Common Stock
TMTS
$1.29M ﹤0.01%
127,618
-146,208
-53% -$1.47M
FHTX icon
4358
Foghorn Therapeutics
FHTX
$356M
$1.29M ﹤0.01%
92,633
-103,129
-53% -$1.14M
SWSSU
4359
DELISTED
Clean Energy Special Situations Corp. Unit
SWSSU
$1.29M ﹤0.01%
+258,508
New +$1.28M
RICK icon
4360
RCI Hospitality Holdings
RICK
$231M
$1.29M ﹤0.01%
18,817
+4,508
+32% +$295K
CHMI
4361
Cherry Hill Mortgage Investment Corp
CHMI
$108M
$1.29M ﹤0.01%
144,934
-91,882
-39% -$846K
AAIC
4362
DELISTED
Arlington Asset Investment Corp.
AAIC
$1.29M ﹤0.01%
347,795
-212,597
-38% -$810K
STAA icon
4363
PUT
STAAR Surgical
STAA
$1.11B
$1.28M ﹤0.01%
10,000
-40,000
-80% -$5.6M
FONR
4364
DELISTED
Fonar
FONR
$1.28M ﹤0.01%
82,968
-32,422
-28% -$550K
KOD icon
4365
Kodiak Sciences
KOD
$2.37B
$1.28M ﹤0.01%
13,352
-52,533
-80% -$4.85M
KMX icon
4366
CALL
CarMax
KMX
$8.81B
$1.28M ﹤0.01%
+10,000
New +$1.33M
KMX icon
4367
PUT
CarMax
KMX
$8.81B
$1.28M ﹤0.01%
+10,000
New +$1.33M
ACBI
4368
DELISTED
Atlantic Capital Bancshares, Inc. Common Stock
ACBI
$1.28M ﹤0.01%
48,296
-25,765
-35% -$628K
NTB icon
4369
Bank of N.T. Butterfield & Son
NTB
$2.33B
$1.28M ﹤0.01%
35,983
-30,817
-46% -$1.04M
PRLD icon
4370
Prelude Therapeutics
PRLD
$437M
$1.28M ﹤0.01%
40,851
+19,893
+95% +$644K
PLCE icon
4371
Children's Place
PLCE
$54.9M
$1.27M ﹤0.01%
16,947
-87,044
-84% -$7.72M
DBD
4372
DELISTED
Diebold Nixdorf Incorporated
DBD
$1.27M ﹤0.01%
126,051
+37,378
+42% +$410K
REKR icon
4373
Rekor Systems
REKR
$75.5M
$1.27M ﹤0.01%
110,825
+40,404
+57% +$367K
ULH icon
4374
Universal Logistics Holdings
ULH
$515M
$1.27M ﹤0.01%
63,364
-4,277
-6% -$92.5K
ELME
4375
Elme Communities
ELME
$149M
$1.27M ﹤0.01%
51,363
+33,968
+195% +$835K
173 174
175
176 177

Similar funds

AQR Capital Management
AQR Capital Management Greenwich, Connecticut $287B AUM 42.33% 1-Year Est. Return
BNP Paribas Financial Markets
BNP Paribas Financial Markets Paris, France $289B AUM 60.46% 1-Year Est. Return
Berkshire Hathaway
Berkshire Hathaway Omaha, Nebraska $299B AUM 27.55% 1-Year Est. Return
AllianceBernstein
AllianceBernstein Nashville, Tennessee $302B AUM 26.44% 1-Year Est. Return
Citigroup
Citigroup New York $303B AUM 53.02% 1-Year Est. Return
Jones Financial Companies
Jones Financial Companies Des Peres, Missouri $250B AUM 21.32% 1-Year Est. Return
Bank of Montreal
Bank of Montreal Toronto, Ontario, Canada $304B AUM 35.64% 1-Year Est. Return
JT
Jupiter Topco New York $245B AUM

Israel Englander's Q3 2021 Portfolio in Review

As of Q3 2021, Israel Englander held 7,698 positions worth $167B, up 2.3% from $163B the previous quarter. Its ten largest holdings account for 18% of the portfolio.

Israel Englander's Q3 2021 filing shows 1,245 new, 2,719 increased, 2,446 reduced and 981 closed positions. Its largest new stake was Sight Sciences: 1,577,092 shares worth $35.8M. The largest sale was Alexion Pharmaceuticals, an estimated $887M.

By sector, the portfolio is most concentrated in Miscellaneous at 58% of assets, up from 55% a quarter earlier, followed by Technology and Financials.

  • Israel Englander's largest Q3 2021 buy was Sight Sciences: 1,577,092 shares worth $35.8M.
  • Israel Englander added most to State Street SPDR S&P 500 ETF Trust in Q3 2021, an estimated $643M increase.
  • Israel Englander's biggest Q3 2021 reduction was Apple, cutting an estimated $694M.
  • Israel Englander fully exited Alexion Pharmaceuticals in Q3 2021, selling an estimated $887M.
  • Israel Englander's ten largest holdings make up 18% of its $167B portfolio in Q3 2021.
  • Israel Englander opened 1,245 new positions and closed 981 in Q3 2021.
  • Israel Englander's portfolio value rose 2.3% quarter-over-quarter to $167B.

Based on Millennium Management's 13F filing for Q3 2021, filed 15 Nov 2021.